About Dexcel Pharma
Dexcel Pharma is a company based in Or Akiva (Israel). It operates as a Direct-to-Consumer (D2C) and Reseller / Distribution. Dexcel Pharma offers products and services including Branded Rx, OTC Products, and Generics.
- Headquarter Or Akiva, Israel
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Dexcel Pharma
Dexcel Pharma offers a comprehensive portfolio of products and services, including Branded Rx, OTC Products, and Generics.
Innovative drugs are offered across various therapeutic areas.
National brands and private-label pharmaceuticals are provided.
Broad portfolio of niche generics is commercialized globally.
People of Dexcel Pharma
Unlock access to complete
Funding Insights of Dexcel Pharma
Detailed funding history for Dexcel Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Dexcel Pharma
Investment portfolio details for Dexcel Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Dexcel Pharma
Detailed financials for Dexcel Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dexcel Pharma Comparisons
Peer comparison for Dexcel Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Dexcel Pharma
Detailed competitors of Dexcel Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dexcel Pharma
Complete news archive for Dexcel Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dexcel Pharma
Dexcel Pharma is headquartered in Or Akiva, Israel. It is registered at Or Akiva, Central District, Israel.
Dexcel Pharma is involved in the development, manufacturing, and commercialization of innovative and generic pharmaceutical products worldwide. Operations are focused on branded prescription drugs, over-the-counter products, and a broad portfolio of generics across various dosage forms. The company is committed to research and development in small molecules, biologics, oligonucleotides, and genetic medicine. Key markets include the United States, Israel, Germany, the United Kingdom, and Austria, supported by a global network of affiliates and distributors.
Dexcel Pharma offers Branded Rx, OTC Products, and Generics.